Literature DB >> 21121722

Cranial bone defects: current and future strategies.

Caroline Szpalski1, Jason Barr, Meredith Wetterau, Pierre B Saadeh, Stephen M Warren.   

Abstract

Bony defects in the craniomaxillofacial skeleton remain a major and challenging health concern. Surgeons have been trying for centuries to restore functionality and aesthetic appearance using autografts, allografts, and even xenografts without entirely satisfactory results. As a result, physicians, scientists, and engineers have been trying for the past few decades to develop new techniques to improve bone growth and bone healing. In this review, the authors summarize the advantages and limitations of current animal models; describe current materials used as scaffolds, cell-based, and protein-based therapies; and lastly highlight areas for future investigation. The purpose of this review is to highlight the major scaffold-, cell-, and protein-based preclinical tools that are currently being developed to repair cranial defects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21121722     DOI: 10.3171/2010.9.FOCUS10201

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  53 in total

1.  Incorporation of Collagen from Marine Sponges (Spongin) into Hydroxyapatite Samples: Characterization and In Vitro Biological Evaluation.

Authors:  J R Parisi; K R Fernandes; I R Avanzi; B P Dorileo; A F Santana; A L Andrade; P R Gabbai-Armelin; C A Fortulan; E S Trichês; R N Granito; A C M Renno
Journal:  Mar Biotechnol (NY)       Date:  2018-09-14       Impact factor: 3.619

Review 2.  The role of vertebrate models in understanding craniosynostosis.

Authors:  Greg Holmes
Journal:  Childs Nerv Syst       Date:  2012-08-08       Impact factor: 1.475

3.  Evaluation of BMP-2 gene-activated muscle grafts for cranial defect repair.

Authors:  Fangjun Liu; Ryan M Porter; James Wells; Vaida Glatt; Carmencita Pilapil; Christopher H Evans
Journal:  J Orthop Res       Date:  2011-12-28       Impact factor: 3.494

4.  A comparison of tissue engineering based repair of calvarial defects using adipose stem cells from normal and osteoporotic rats.

Authors:  Ming Pei; Jingting Li; David B McConda; Sijin Wen; Nina B Clovis; Suzanne S Danley
Journal:  Bone       Date:  2015-05-01       Impact factor: 4.398

5.  Meningeal inflammatory response and fibrous tissue remodeling around intracortical implants: An in vivo two-photon imaging study.

Authors:  J R Eles; A L Vazquez; T D Y Kozai; X T Cui
Journal:  Biomaterials       Date:  2018-12-31       Impact factor: 12.479

6.  Osteogenesis of Crouzon-Mutated Cells in an Experimental Model.

Authors:  Andre Alcon; Philipp Metzler; Jacob Eswarakumar; Alexander T Wilson; Derek M Steinbacher
Journal:  J Craniofac Surg       Date:  2018-01       Impact factor: 1.046

7.  Self-assembling peptide nanofibers coupled with neuropeptide substance P for bone tissue engineering.

Authors:  Su Hee Kim; Woojune Hur; Ji Eun Kim; Hye Jeong Min; Sukwha Kim; Hye Sook Min; Byeung Kyu Kim; Soo Hyun Kim; Tae Hyun Choi; Youngmee Jung
Journal:  Tissue Eng Part A       Date:  2015-01-13       Impact factor: 3.845

8.  Coactivation of Endogenous Wnt10b and Foxc2 by CRISPR Activation Enhances BMSC Osteogenesis and Promotes Calvarial Bone Regeneration.

Authors:  Mu-Nung Hsu; Kai-Lun Huang; Fu-Jen Yu; Po-Liang Lai; Anh Vu Truong; Mei-Wei Lin; Nuong Thi Kieu Nguyen; Chih-Che Shen; Shiaw-Min Hwang; Yu-Han Chang; Yu-Chen Hu
Journal:  Mol Ther       Date:  2019-12-06       Impact factor: 11.454

9.  PTH promotes allograft integration in a calvarial bone defect.

Authors:  Dmitriy Sheyn; Doron Cohn Yakubovich; Ilan Kallai; Susan Su; Xiaoyu Da; Gadi Pelled; Wafa Tawackoli; Galen Cook-Weins; Edward M Schwarz; Dan Gazit; Zulma Gazit
Journal:  Mol Pharm       Date:  2013-11-08       Impact factor: 4.939

10.  Human amniotic fluid stem cells attract osteoprogenitor cells in bone healing.

Authors:  Mariangela Basile; Francesco Marchegiani; Sanja Novak; Ivo Kalajzic; Roberta Di Pietro
Journal:  J Cell Physiol       Date:  2019-10-24       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.